Schneider Children's Medical Center of Idrael
Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes
Prof. Moshe Phillip graduated (MD) from Ben Gurion University, Beer Sheba, Israel in 1983, specialized in Pediatrics at Soroka Medical Center in Beer Sheba, Israel and in pediatric endocrinology in 1989-1992 at the University of Maryland School of Medicine in Baltimore. Since 1997 he is the director of the Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes at Schneider Children’s Medical Center, Petah Tikva and serves as Vice Dean for Research and Development as well as a Chair of the Irene and Nicholas Marsh Fund for Endocrinology and Diabetes at Sackler Faculty of Medicine, Tel-Aviv University. Previously (1992-1997) he served as division head in Pediatric Diagnostic and Therapeutic Center at Soroka Medical Center in Beer-Sheba. Prof. Phillip is active in both clinical and basic research in various endocrine issues, focusing on childhood diabetes as well as developing technologies for the treatment of diabetes, and the interaction between nutrition and growth. Prof. Phillip is an active member of national and international organizations such as the Israeli National Committee for Diabetes, International Society of Pediatric and Adolescent Diabetes (ISPAD), The European Society for Pediatric Endocrinology (ESPE), Pediatric Endocrine Society (PES), Endocrine Society, American Diabetes Association (ADA) and more. In the framework of these organizations, he has organized many seminars, schools and consensus meetings dealing with topics in endocrinology and diabetes. Prof. Phillip is co-chairman of the Annual International Conference for Advanced Technologies and Treatments of Diabetes (ATTD) and of the International conference on Nutrition and Growth (N&G). Prof. Phillip has published more than 400 manuscripts, as well as books (including the ATTD and N&G Yearbooks) and chapters in books.

Moderator Of 6 Sessions

Session Type
ATTD FORUM
Date
Thu, 28.04.2022
Session Time
16:45 - 17:45
Room
Hall 116
Session Type
Industry Symposium
Date
Wed, 27.04.2022
Session Time
14:30 - 16:00
Room
Hall 113
Session Description
Eversense CGM System - Clinical perspectives and innovation pathway - Industry Symposium Supported by Ascensia Diabetes Care

Session Description:

An overview of the factors influencing the effectiveness of CGM systems. Discuss expectations and documented evidence for the use of the Eversense CGM System.

Exchange of clinical experiences related to the use of the long-term, implantable CGM. Insight into the research and development of Eversense.

Session Type
Industry Symposium
Date
Wed, 27.04.2022
Session Time
16:15 - 17:45
Room
Hall 114
Session Description
Optimizing management of chronic kidney disease and Type 2 diabetes: Benefits of non-steroidal MR antagonists - Industry Symposium Supported by Sciarc GmbH

Session Description:

It is estimated that more than 160 million patients worldwide live with chronic kidney disease and type 2 diabetes. They are at high risk for cardiovascular events and progressive renal failure. Unmet educational needs of HCPs include optimizing management of chronic kidney disease and Type 2 diabetes will be summarized. With the development of nonsteroidal mineralocorticoid receptor antagonists (MRA), the safety profile of MRA has also improved significantly, making mineralocorticoid receptor antagonism a potential, highly effective treatment option for slowing the progression of CKD in T2D. Finerenone is such novel nonsteroidal selective MRA with a high MR selectivity compared to spironolactone. It has favourable effects on cardiorenal outcomes in patients with stage 3 or 4 chronic kidney disease with increased albuminuria and type 2 diabetes. Two large trials ((FIDELIO-DKD, FIGARO-DKD) evaluated the effects of Finerenone on cardiorenal outcomes and demonstrated significant favourable effects. Results of these studies will be discussed. New treatment approaches for chronic kidney disease in diabetes will be highlighted.

Session Type
Plenary Session
Date
Fri, 29.04.2022
Session Time
13:00 - 14:30
Room
Hall 116
Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
12:10 - 12:30
Room
Hall 111

Presenter Of 13 Presentations

International Fair of New Technologies in Diabetes

Session Type
Press Conference
Date
Thu, 28.04.2022
Session Time
10:30 - 11:30
Room
Hall 118
Lecture Time
11:00 - 11:10

Highlights from the international consensus meeting on Automated Insulin Delivery (AID)

Session Type
Plenary Session
Date
Sat, 30.04.2022
Session Time
09:00 - 10:40
Room
Hall 112
Lecture Time
10:20 - 10:40

Welcome & Introduction

Session Type
Industry Symposium
Date
Wed, 27.04.2022
Session Time
16:15 - 17:45
Room
Hall 114
Lecture Time
16:15 - 16:20

Invitation to ATTD 2023 in Berlin

Session Type
Press Conference
Date
Thu, 28.04.2022
Session Time
10:30 - 11:30
Room
Hall 118
Lecture Time
11:10 - 11:15

Antibody Detection Israel Research (ADIR) project

Session Type
Plenary Session
Date
Sat, 30.04.2022
Session Time
14:35 - 16:15
Room
Hall 112
Lecture Time
14:55 - 15:15

Discussion & Closure

Session Type
Industry Symposium
Date
Wed, 27.04.2022
Session Time
16:15 - 17:45
Room
Hall 114
Lecture Time
17:20 - 17:45

Current agreement on the CGM-derived metrics in clinical trials

Session Type
Parallel Session
Date
Sat, 30.04.2022
Session Time
12:10 - 12:30
Room
Hall 111
Lecture Time
12:20 - 12:30

Online First Release - Part 1

Session Type
ATTD FORUM
Date
Thu, 28.04.2022
Session Time
16:45 - 17:45
Room
Hall 116
Lecture Time
16:45 - 17:15

Opening Remarks

Session Type
Opening / Closing
Date
Wed, 27.04.2022
Session Time
18:00 - 19:00
Room
Hall 116
Lecture Time
18:00 - 18:10

Closing remarks - 100 Years Insulin Prize & Farewell Refreshments

Session Type
Plenary Session
Date
Sat, 30.04.2022
Session Time
14:35 - 16:15
Room
Hall 112
Lecture Time
15:45 - 16:15

Welcome Words

Session Type
Press Conference
Date
Thu, 28.04.2022
Session Time
10:30 - 11:30
Room
Hall 118
Lecture Time
10:30 - 10:45

Artificial Intelligence based decision support system

Session Type
Plenary Session
Date
Thu, 28.04.2022
Session Time
09:00 - 10:00
Room
Hall 116
Lecture Time
09:40 - 10:00

“Why?” In Pursuit of CGM effectiveness

Session Type
Industry Symposium
Date
Wed, 27.04.2022
Session Time
14:30 - 16:00
Room
Hall 113
Lecture Time
14:30 - 14:50